26th Bethesda conference: recommendations for determining eligibility for competition in athletes with cardiovascular abnormalities. Task Force 3: hypertrophic cardiomyopathy, myocarditis and other myopericardial diseases and mitral valve prolapse (Q40634818)
scientific article published on October 1994
Language:
Current Data About 26th Bethesda conference: recommendations for determining eligibility for competition in athletes with cardiovascular abnormalities. Task Force 3: hypertrophic cardiomyopathy, myocarditis and other myopericardial diseases and mitral valve prolapse
(P31) (Q13442814)
(P248)
(P698) 7930220
(P813) Friday, September 22, 2017

(P304) 880-885
(P248)
(P698) 7930220
(P813) Friday, September 22, 2017

(P407) (Q1860)

(P433) 4
(P248)
(P698) 7930220
(P813) Friday, September 22, 2017

(P478) 24
(P248)
(P698) 7930220
(P813) Friday, September 22, 2017

(P577) Saturday, October 1, 1994
(P248)
(P698) 7930220
(P813) Friday, September 22, 2017

(P921) (Q1364270)
(P887)

(Q186235)
(P887)

(P1433) (Q2984355)
(P248)
(P698) 7930220
(P813) Friday, September 22, 2017

(P1476) "26th Bethesda conference: recommendations for determining eligibility for competition in athletes with cardiovascular abnormalities. Task Force 3: hypertrophic cardiomyopathy, myocarditis and other myopericardial diseases and mitral valve prolapse" (language: en)
(P248)
(P698) 7930220
(P813) Friday, September 22, 2017

(P2093) B J Maron
(P1545) 1
(P248)
(P698) 7930220
(P813) Friday, September 22, 2017

J M Isner
(P1545) 2
(P248)
(P698) 7930220
(P813) Friday, September 22, 2017

W J McKenna
(P1545) 3
(P248)
(P698) 7930220
(P813) Friday, September 22, 2017

(P13046) (Q7318358)
(P248)

other details
description scientific article published on October 1994

External Links
(P356) 10.1016/0735-1097(94)90844-3
(P698) 7930220
(P5875) 246507258